|
KMID : 0361620230580030245
|
|
Journal of the Korean Orthopaedic Association
2023 Volume.58 No. 3 p.245 ~ p.256
|
|
|
Effectiveness of Intra-Articular Injections of Polynucleotides in Korean Patients with Knee Osteoarthritis in a Real Clinical Field
|
|
Kim Wan-Ho
Sung Byung-Yoon
Song Young-Sun
Hong Jun-Seok
Ryu Ho-Kwang
Kim Kug-Jin
Park Jong-Hoon
Kim Jong-Soon
Kim Dong-Hu
Son Il-Nam
|
|
|
Abstract
|
|
|
Purpose: This observational study was conducted to confirm the effectiveness and safety of intra-articular injection of polynucleotides in Korean patients with knee osteoarthritis (OA) in a real clinical setting.
Materials and Methods: Five hundred and forty-six cases of patients who received three?five times of injections of polynucleotides within six months and then visited were enrolled from December 2020 to February 2022. The subjects were then followed up for six months. The pain reduction effect was evaluated using a 100 mm-weight bearing pain visual analogue scale (VAS) before administration, immediately after administration, and three and six months after the injection cycle. Then the results were analyzed as an entire group and sub-group. In addition, the tendency of Clinical Global Impression (CGI) and the Patient Global Impression (PGI) at each time point and adverse events were investigated.
Results: An analysis of the VAS in the entire group analysis revealed a more than 50% reduction of pain vs. pre-administration that was maintained for six months from the end of the Conjuran® treatment. Approximately 40%?60% reductions of pain were observed in subgroup analysis according to age, Kellgren?Lawrence (KL)-grade, and pain at pre-administration. At all time points, these pain relief effects were significant (p<0.001) compared to pre-administration, regardless of any factors of sub-group analysis. Moreover, in CGI, 77.8% of patients reported that their symptoms improved after six months from the completion of treatment. In addition, in PGI, 75.6% of patients self-evaluated that the symptoms improved after six months from the completion of treatment. No serious adverse events were reported.
Conclusion: An intra-articular injection of polynucleotides to knee OA patients in the clinical field showed significant pain reduction effectiveness for six months after treatment, and no other serious case was reported. Therefore, this is considered a therapeutical option in an intra-articular injection that can be used safely in a real clinical setting. In particular, sub-analysis of the factors considered to affect the symptoms of knee OA, such as age, KL-grade, and pain level before administration, revealed significant pain improvement in all factors and aspects. Therefore, intra-articular injection of polynucleotides is expected to be an effective therapeutic option in knee OA.
|
|
|
KEYWORD
|
|
|
knee, osteoarthritis, injections intra-articular, polynucleotides, observational study
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|
|